Furthermore, overexpression of ADAM Metallopeptidase with Thrombospondin Type 1 Motif 5 (ADAMTS5) is associated with poor prognosis in lung cancer patients, and Liu and Yao et al. proved that ADAMTS5 is targeted by miR-200c-5p [45,46]. The gene discussed is ADAMTS5; the disease is lung carcinoma.